Feature Channels: Personalized Medicine

Filters close
Newswise: International Precision Neuroscience Conference to Explore Brain Cancer, Mental Health, Neurodegeneration
Released: 3-Apr-2022 12:05 PM EDT
International Precision Neuroscience Conference to Explore Brain Cancer, Mental Health, Neurodegeneration
Virginia Tech

The Precision Neuroscience Conference builds on a collaboration between Nordic and Virginia universities. It will be held at Virginia Tech and feature scientists presenting work involving forward-looking applications of precision medicine.

Released: 29-Mar-2022 2:55 PM EDT
妙佑医疗国际研究发现纳米孔测序法可快速检测和鉴定抗生素耐药性微生物
Mayo Clinic

有越来越多人因抗生素耐药性感染而面临死亡。此类感染是微生物物种通过突变以躲避制药破坏性攻击所引发的。仅2019年,全球便有超过120万人死于抗生素耐药性感染。

Released: 29-Mar-2022 2:50 PM EDT
أبحاث مايو كلينك تُظهر أن أسلوب تسلسل الثقوب النانوية يكتشف ويحدد الميكروبات المقاومة للمضادات الحيوية بسرعة
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا- يموت عدد متزايد من الناس بسبب العَدوى المقاومة للمضادات الحيوية. وهذه العَدوى تغذيها أنواع الميكروبات التي تتحور لتتجنب الأدوية المطورة بهدف تدميرها. توفي أكثر من 1.2 مليون شخص حول العالم في عام 2019 بسبب العَدوى المقاومة للمضادات الحيوية.

Released: 29-Mar-2022 1:45 PM EDT
Pesquisa da Mayo Clinic mostra que método de sequenciamento por nanoporos detecta e identifica rapidamente micróbios resistentes a antibióticos
Mayo Clinic

Cada vez mais pessoas estão morrendo por infecções resistentes a antibióticos. Essas infecções são alimentadas por espécies microbianas que estão em mutação para escapar das drogas desenvolvidas para destruí-las.

Released: 29-Mar-2022 1:35 PM EDT
El método de secuenciación de nanoporos detecta e identifica rápidamente microbios resistentes a antibióticos, demuestra estudio de Mayo Clinic
Mayo Clinic

Una creciente cantidad de personas muere debido a infecciones resistentes a los antibióticos. Estas infecciones son propiciadas por especies bacterianas que mutan a fin de evadir a los fármacos creados para destruirlas.

21-Mar-2022 8:05 AM EDT
Novel Therapeutic Strategy Shows Promise Against Pancreatic Cancer
Albert Einstein College of Medicine

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%. The paper describing the findings published online today in Science Translational Medicine.

Released: 22-Mar-2022 11:25 AM EDT
Study involving investigators from Mayo Clinic, Baylor College of Medicine applies drug-gene testing to improve patient care and reports outcomes
Mayo Clinic

In a newly published study appearing in Genetics in Medicine, investigators from Mayo Clinic and Baylor College of Medicine found that targeted genomic information can play an important role in drug prescribing practices.

Released: 21-Mar-2022 5:25 PM EDT
妙佑医疗国际的研究人员使用人工智能预测抗抑郁药物在年轻患者中的治疗结果
Mayo Clinic

妙佑医疗国际(Mayo Clinic) 的研究人员迈出第一步,使用人工智能(AI)预测患有重度抑郁障碍的儿童和青少年在服用抗抑郁药物后的早期结果。

Released: 21-Mar-2022 5:20 PM EDT
باحثو مايو كلينك يستخدمون الذكاء الاصطناعي للتنبؤ بنتائج مضادات الاكتئاب على الشباب
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا― أخذ باحثو مايو كلينك الخطوة الأولى في استخدام الذكاء الاصطناعي (AI) للتنبؤ بالنتائج المبكرة لاستخدام مضادات الاكتئاب لدى الأطفال والمراهقين المصابين باضطراب اكتئابي شديد.

Released: 21-Mar-2022 5:20 PM EDT
Pesquisadores da Mayo Clinic usam IA para prever resultados do uso de antidepressivos em jovens
Mayo Clinic

Pesquisadores da Mayo Clinic deram o primeiro passo para usar a inteligência artificial (IA) para prever os resultados iniciais do uso de antidepressivos em crianças e adolescentes com transtorno depressivo maior.

Released: 21-Mar-2022 5:15 PM EDT
Investigadores de Mayo Clinic aplican inteligencia artificial para predecir resultado de antidepresivos en niños y jóvenes
Mayo Clinic

Los investigadores de Mayo Clinic dieron el primer paso en la aplicación de la inteligencia artificial con el fin de predecir antes el resultado de los antidepresivos en los niños y los adolescentes que sufren algún trastorno depresivo mayor.

Newswise: U.S. Precision Medicine Research Program Releases Genomic Data
Released: 18-Mar-2022 11:10 AM EDT
U.S. Precision Medicine Research Program Releases Genomic Data
Vanderbilt University Medical Center

Earlier this month the All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.

Released: 16-Mar-2022 11:35 AM EDT
Mayo Clinic researchers use AI to predict antidepressant outcomes in youth
Mayo Clinic

Mayo Clinic researchers have taken the first step in using artificial intelligence (AI) to predict early outcomes with antidepressants in children and adolescents with major depressive disorder, in a study published in The Journal of Child Psychology and Psychiatry.

Released: 15-Mar-2022 10:50 AM EDT
Novel CRISPR Imaging Technology Reveals Genes Controlling Tumor Immunity
Mount Sinai Health System

Mount Sinai scientists have developed a new technology allowing them to link specific genes to complex tumor characteristics at a scale and resolution not previously possible. The results could lead to new approaches for targeting anti-cancer drugs.

Newswise:Video Embedded uci-scientists-make-leap-forward-for-genetic-sequencing
VIDEO
Released: 11-Mar-2022 2:45 PM EST
UCI scientists make leap forward for genetic sequencing
University of California, Irvine

Irvine, Calif., March 11, 2022 — In a paper published today in Sciences Advances, researchers in the Department of Chemistry and the Department of Physics & Astronomy at the University of California, Irvine revealed new details about a key enzyme that makes DNA sequencing possible. The finding is a leap forward into the era of personalized medicine when doctors will be able to design treatments based on the genomes of individual patients.

Newswise: Chula Announces the “Personalized Cancer Vaccine” Project
Released: 28-Feb-2022 8:55 AM EST
Chula Announces the “Personalized Cancer Vaccine” Project
Chulalongkorn University

Bangkok, February 10, 2022 – Chulalongkorn University held a Chula the Impact 7 Seminar on “the Progress of Personalized, Therapeutic Cancer Vaccine: An Innovation of Hope for Thai Society” by the CU Cancer Immunotherapy Excellence Center, Faculty of Medicine, and the King Chulalongkorn Memorial Hospital, Thai Red Cross Society, funded by the Second Century Fund, Chulalongkorn University (C2F).

Released: 24-Feb-2022 3:05 PM EST
Machine Learning Antibiotic Prescriptions Can Help Minimize Resistance Spread
American Technion Society

Using genomic sequencing techniques and machine learning analysis of patient records, Israeli researchers have developed an antibiotic prescribing algorithm that cuts the risk of emergence of antibiotic resistance by half.

17-Feb-2022 3:35 PM EST
The Latest Research News in Cardiovascular Health
Newswise

The Latest Research News in Cardiovascular Health

Newswise: One Patient, Two Cancers, Multiple Experts: A Path Forward in a Day
Released: 22-Feb-2022 6:05 AM EST
One Patient, Two Cancers, Multiple Experts: A Path Forward in a Day
Cedars-Sinai

Maxine Aubry, a paragon of health for most of her 81 years, was shocked by the back-to-back cancer diagnoses she received last summer - an aggressive cancer in her left breast in June, followed by a pancreatic cancer diagnosis.

Newswise: Q&A With Arun Sharma, PhD: The Heart Modeler
Released: 21-Feb-2022 4:05 PM EST
Q&A With Arun Sharma, PhD: The Heart Modeler
Cedars-Sinai

Cancer treatments save lives. They also might cause heart damage in the process. Cedars-Sinai research scientist Arun Sharma, PhD, wants to be able to predict when this might happen, and is creating models of the human heart by using stem cells derived from blood. The goal is to better personalize cancer treatments.

Newswise: UCI announces launch of Institute for Precision Health
Released: 15-Feb-2022 12:20 PM EST
UCI announces launch of Institute for Precision Health
University of California, Irvine

Irvine, Calif., Feb. 15, 2022 — The University of California, Irvine today announced the launch of the Institute for Precision Health, an endeavor that marries UCI’s powerhouse health sciences, engineering, machine learning, artificial intelligence, clinical genomics and data science capabilities to deliver the most effective health and wellness strategy for each individual person and, in doing so, confronts the linked challenges of health equity and the high cost of care.

Released: 14-Feb-2022 3:30 PM EST
Roswell Park Sequencing Study Unlocks Mystery of Multiple Myeloma
Roswell Park Comprehensive Cancer Center

In 1873, Russian doctor J. von Rusitzky coined the term “multiple myeloma” after finding eight different types of bone marrow tumors in a single patient. Nearly 150 years later, using advanced cell sequencing technology and state-of-the-art imaging techniques, researchers at Roswell Park Comprehensive Cancer Center have provided a molecular and biological explanation for this finding, discovering that different myeloma clones can be present in a single patient and linking these distinct genetic changes in myeloma cells to the development of myeloma bone disease.

Released: 11-Feb-2022 4:45 PM EST
The latest research news in Physics for the media
Newswise

Here are some of the latest articles we've posted in the Physical Science channel.

       
1-Feb-2022 7:00 AM EST
UCLA Jonsson Comprehensive Cancer Center scientists identify germline signature that predicts side effects from anti-PD1/PDL1 checkpoint therapy
University of California, Los Angeles (UCLA), Health Sciences

Investigators from UCLA Jonsson Comprehensive Cancer Center have identified a germline biomarker signature that successfully predicts which patients will suffer serious side effects that occur in up to three in 10 patients on anti-PD1/PDL1 therapy, a promising new approach to treating cancer.

Released: 26-Jan-2022 1:45 PM EST
The latest news in Behavioral Science for media
Newswise

Here are some of the latest articles we've posted in the Behavioral Science channel.

       
Newswise: Most “Pathogenic” Genetic Variants Have a Low Risk of Causing Disease
21-Jan-2022 2:05 PM EST
Most “Pathogenic” Genetic Variants Have a Low Risk of Causing Disease
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai discovered that the chance a pathogenic genetic variant may actually cause a disease is relatively low - about 7 percent. They also found that some variants, such as those associated with breast cancer, are linked to a wide range of risks for disease. The results could alter the way the risks associated with these variants are reported, and one day, help guide the way physicians interpret genetic testing results.

Released: 24-Jan-2022 3:40 PM EST
The Latest Research News from the Health Disparities Channel
Newswise

The latest research news from the Health Disparities Channel.

Released: 20-Jan-2022 1:05 PM EST
Cornell to co-lead NIH center for precision nutrition research
Cornell University

A five-year, $23 million award from the National Institutes of Health will put Cornell at the center of a significant federal investment in research aimed at customizing nutrition guidance.

Newswise: HNRCA Launches National Center for Precision Health
Released: 20-Jan-2022 10:00 AM EST
HNRCA Launches National Center for Precision Health
Tufts University

Tufts' HNRCA will lead a new study to develop algorithms to predict how individuals respond to different food and dietary patterns. Funded by the National Institutes of Health, researchers are hopeful the initiative will lead to more personalized nutrition guidance.

Newswise: UC San Diego Receives $14M to Drive Precision Nutrition with Gut Microbiome Data
Released: 20-Jan-2022 10:00 AM EST
UC San Diego Receives $14M to Drive Precision Nutrition with Gut Microbiome Data
UC San Diego Health

National Institutes of Health establishes Microbiome and Metagenomics Center at UC San Diego, part of new effort to predict individual responses to food and inform personalized nutrition recommendations.

Newswise: UCI-led team develops new biopsy technology for analyzing multiple tumor tissue biomarkers
Released: 10-Jan-2022 12:45 PM EST
UCI-led team develops new biopsy technology for analyzing multiple tumor tissue biomarkers
University of California, Irvine

Irvine, Calif., Jan. 10, 2022 – A team led by University of California, Irvine researchers has developed a new biopsy technology that can profile multiple tumor microenvironment biomarkers simultaneously, revealing cellular spatial organization and interactions that will help advance personalized disease diagnosis and treatment.

Newswise: A Breakthrough in Probiotic Therapy – Personalized Probiotics (Dispensing) Machine for a Balanced and Enhanced Immune System
Released: 23-Dec-2021 8:55 AM EST
A Breakthrough in Probiotic Therapy – Personalized Probiotics (Dispensing) Machine for a Balanced and Enhanced Immune System
Chulalongkorn University

MED-CU has invented a Personalized Probiotics (Dispensing) Machine to deliver live microorganisms that have health benefits to treat patients with unclear health problems and those with microbial imbalances or “dysbiosis”.

Released: 17-Dec-2021 10:05 AM EST
Mayo Clinic researchers use AI, biomarkers to personalize rheumatoid arthritis treatment
Mayo Clinic

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.

Released: 15-Dec-2021 4:45 PM EST
The Latest Mental Health Research and Feature News in the Mental Health Channel on Newswise
Newswise

The Latest Mental Health Research and Feature News in the Mental Health Channel on Newswise

       
Released: 7-Dec-2021 2:30 PM EST
NCCN Summit Explores How to Better Deliver on the Promise of Precision Medicine for People with Cancer
National Comprehensive Cancer Network® (NCCN®)

Rapid advances in biomarker research improve outcomes for people with cancer. National Comprehensive Cancer Network Patient Advocacy Summit looks at policy and practice solutions to increase equitable access for all.

Released: 7-Dec-2021 8:05 AM EST
Study shows how bias can creep into medical databanks that drive precision health and clinical AI
Michigan Medicine - University of Michigan

Racial and ethnic diversity in biobanks and genetic databases is crucial for the accuracy of artificial intelligence (AI) and biomarker research and products. But a new study shows how bias can creep in.

Released: 29-Nov-2021 1:50 PM EST
UT Southwestern launches SPORE-funded national resource to advance precision medicine for kidney cancer
UT Southwestern Medical Center

Funded by a Specialized Program of Research Excellence (SPORE) award from the National Cancer Institute (NCI), the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center reports the largest and most diverse catalog of kidney cancer tumor models to date.

Newswise: Prostate Cancer Organoids Open Path to Precision Oncology
Released: 24-Nov-2021 8:40 AM EST
Prostate Cancer Organoids Open Path to Precision Oncology
Georgia Institute of Technology

A multi-institutional team of investigators led by bioengineer Ankur Singh has developed organoids which that shed new light on a virtually untreatable form of prostate cancer, opening a pathway that may lead to novel therapeutics and a glimmer of hope for patients.

Released: 23-Nov-2021 10:45 AM EST
AI predicts treatment response and survival in small cell lung cancer patients
Case Western Reserve University

Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have used artificial intelligence (AI) to identify patterns on computed tomography (CT) scans that offer new promise for treating patients with small cell lung cancer. Small cell lung cancer (SCLC) represents about 13% of all lung cancers, but grows faster and is more likely to spread than non-small cell lung cancer, according to the American Cancer Society.

Newswise: Young Adult Cancer Patients May Need Different Treatment Options
11-Nov-2021 2:35 PM EST
Young Adult Cancer Patients May Need Different Treatment Options
Mount Sinai Health System

Young adults who are diagnosed with skin, colon, and other cancer types may require different treatments than older patients receive. That is the primary conclusion of a Mount Sinai study which systematically compared the genomes of 14 different types of cancers that affected both younger and older adults.

9-Nov-2021 6:05 PM EST
Study encourages cautious approach to CRISPR therapeutics
Sanford Burnham Prebys

Researchers from Sanford Burnham Prebys and the National Cancer Institute have shown that gene editing with CRISPR may select for certain cancer-associated mutations, highlighting the need for caution when using CRISPR therapeutically.

9-Nov-2021 5:00 PM EST
New Research Helps Explain the Genetic Basis of Why We Look the Way We Do
University of California San Diego

Comparing features of a common laboratory fruit fly with its rarer cousin collected from Hawai’i Volcanoes National Park, UC San Diego researchers used CRISPR technology to uncover clues about how high-level control genes called Hox genes shape our appearance.

Newswise: UTSW-led research identifies new imaging biomarkers that predict antidepressant response
Released: 9-Nov-2021 12:50 PM EST
UTSW-led research identifies new imaging biomarkers that predict antidepressant response
UT Southwestern Medical Center

The outcome predictive models were developed in part using data from a large multi-center National Institute of Mental Health-funded study and published in the journal Biological Psychiatry. The findings provide strong evidence that the current trial-and-error approach used in clinical practice for the selection of the right antidepressant can be replaced with this new precision medicine approach.

Released: 28-Oct-2021 10:10 AM EDT
Personalized medicine research focuses on Hispanics with diabetes in South Texas
University of Texas Health Science Center at Houston

A team of researchers studying genetic data to identify hormone responses in a population of Mexican Americans with prediabetes, Type 2 diabetes, and obesity recently received a $3.5 million grant to fund a five-year study set to begin in late 2021.

Released: 26-Oct-2021 5:05 PM EDT
Multi-Algorithm Approach Helps Deliver Personalized Medicine for Cancer Patients
Georgia Institute of Technology

John F. McDonald and his research team have created a ‘multi-algorithm’ machine learning approach to boost accuracy in predicting drug responses for ovarian cancer patients.

   
Released: 25-Oct-2021 1:55 PM EDT
妙佑医疗国际与Personalis Inc.合作扩大癌症基因组检测
Mayo Clinic

妙佑医疗国际(Mayo Clinic)于10月12日星期二宣布了一项协议,允许其向选择参与的癌症患者提供临床级的全面癌症基因组测序。检测结果将提供给患者及其医疗服务提供者,以指导治疗决策、推进癌症研究,并用于支持新诊断测试和癌症治疗的疗法开发。



close
1.49646